Menu ×

HEALTHCARE & PHARMACEUTICAL

Automated Cell Culture Market Segmentation by Product (Consumables, and Equipment); by Application (Biopharmaceutical Production, Tissue Engineering & Regenerative Medicine, Drug Screening & Development, Gene Therapy, Stem Cell Research, Diagnostics, Toxicity Testing, and Others); and by End-User (Pharmaceutical & Biotechnology Companies, Hospitals & Diagnostic Laboratories, Research & Academic Institutes, and Others) – Global Demand Analysis & Opportunity Outlook 2021-2031

  • Text Size:

Extensive insights into the Growth of Automated Cell Culture Market amidst COVID-19

Get the detailed impact analysis of COVID-19 that has disrupted the entire world and affected many industries.

Request Insights


IN THE NEWS

  • March 11th, 2019: Hitachi, Ltd. announced that for the first time in Japan, it has launched the automated cell mass culture equipment. This equipment, which was first deployed at Sumitomo Dainippon Manufacturing Plant for Regenerative Medicine & Cell Therapy (SMaRT) of Sumitomo Dainippon Pharma Co., Ltd., is able to manufacture commercial iPS cells for regenerative medicine.

  • March 22nd, 2021: Thermo Fisher Scientific Inc. announced that it has launched the new Gibco Human Plasma-like Medium (HPLM), a cell culture medium that mimics the metabolic profile of human plasma. The cell culture medium, which is first of its type, is designed to provide researchers with a realistic view of cell growth within the human body.

Global Automated Cell Culture Market Highlights Over 2021 - 2031

The global automated cell culture market is estimated to garner a revenue of USD 26411.9 Million by the end of 2031 by growing at a CAGR of 8.7% over the forecast period, i.e., 2022 – 2031. Moreover, in the year 2021, the market generated a revenue of USD 11506.8 Million. The growth of the market can majorly be attributed to the rising incidence of chronic and infectious diseases worldwide,  and therefore the need for advanced drugs that can help to treat the patients. According to the statistics by the World Health Organization (WHO), each year 41 Million people are known to die from noncommunicable diseases (NCDs). Moreover, the statistics also stated that between the ages of 30 and 69 years, more than 15 Million people are known to die from a NCD each year. An automated cell culture system allows large-scale production of cells. Since the production process involves high precision technicalities, as well as greater reproducibility and efficiency, hence these processes are known to be highly effective for the manufacturing of advanced drugs that are used for the treatment of different types of chronic diseases.

Automated Cell Culture Market Graph

Get more information on this report: Request Sample PDF

One of the other factors anticipated to drive the growth of the global automated cell culture market is the high manufacturing efficiency of the production process, which significantly lowers the probability of an error as well repetitive manual work, which otherwise are involved in a conventional manufacturing process. Besides this, the surge in investment for research activities in the field of medical science is also expected to create numerous opportunities for market growth during the forecast period.

Global Automated Cell Culture Market Regional Synopsis

Regionally, the global automated cell culture market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in North America is projected to garner the largest revenue of USD 11542.0 Million by the end of 2031, up from a revenue of USD 5104.0 Million in the year 2021. The growth of the market in the region can primarily be attributed to the surge in demand for personalized medicine, surge in R&D activities related to cancer and other chronic diseases, increasing R&D expenditure, and for the presence of major players in the region. According to the statistics by the National Cancer Institute (NCI) of the United States Department of Health and Human Services (National Institutes of Health), the NCI budget for funding for research in cancer touched USD 6440.4 Million by the end of 2020, up from USD 4952.6 Million in the year 2015. On the other hand, the market in Europe is projected to garner the second-largest revenue of USD 6790.5 Million by the end of 2031, up from a revenue of USD 2954.7 Million in the year 2021. The market in the region is further segmented by country into Germany, United Kingdom, Italy, France, Spain, Russia, Netherlands, and the Rest of Europe. The market in Germany is projected to garner the largest revenue of USD 1333.0 Million by the end of 2031, up from a revenue of USD 540.7 Million in the year 2021.

The study further incorporates Y-O-Y Growth, market opportunities, demand & supply and forecast future opportunity in North America (United States, Canada, Mexico), South America, Europe (U.K., Germany, France, Italy, Spain, Hungary, BENELUX [Belgium, Netherlands, Luxembourg], NORDIC [Norway, Denmark, Sweden, Finland], Poland, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Malaysia, Indonesia, Taiwan, Hong Kong, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa).

Growth Drivers and Challenges Impacting the Growth of the Global Automated Cell Culture Market

Growth Drivers

  • Growing Incidence of Chronic and Infectious Diseases
  • Numerous Benefits Associated with the Use of Automated Cell Culture Processes
  • Surge in Investment in Research Activities

Challenges

  • Higher Cost Associated with the Use of the Cell Culture Process

Global Automated Cell Culture Market Segmentation Synopsis

The global automated cell culture market is segmented by product into consumables and equipment, out of which, the equipment segment is anticipated to garner the highest market share by the end of 2031. By application, the market is segmented into biopharmaceutical production, tissue engineering & regenerative medicine, drug screening & development, gene therapy, stem cell research, diagnostics, toxicity testing, and others. The biopharmaceutical production segment is anticipated to garner the largest revenue of USD 5870.5 Million by the end of 2031, up from a revenue of USD 2526.3 Million in the year 2021. By end-user, the market is segmented into pharmaceutical & biotechnology companies, hospitals & diagnostic laboratories, research & academic institutes, and others. The pharmaceutical & biotechnology companies segment is expected to garner the largest revenue of USD 11671.6 Million by the end of 2031, up from a revenue of USD 4845.7 Million in the year 2021.

Key Companies Dominating the Market

Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the global automated cell culture market that are included in our report are Hitachi, Ltd., Thermo Fisher Scientific, Inc., Sartorius AG, Hamilton Company, F. Hoffmann-La Roche Ltd., Merck KGaA, Becton, Dickinson and Company, Cell Culture Company, LLC, Lonza Group, and others.

Key Reasons to Buy Our Report

  • The report covers detailed analysis comprising market share attained by each market segment and its sub-segments.
  • It covers market dynamics including growth drivers, trends, potential opportunities, price trend analysis and challenges that impact the market growth.
  • The report includes detailed company profiles of the major players dominating the market.
  • We use effective research methodologies to calculate the market numbers and provide value-added assessment for overall growth.
  • We provide customized reports as per the clients’ requirement helping them to see possible and unexpected challenges and unforeseen opportunities in order to help them reach their goal.

FREQUENTLY ASKED QUESTIONS

  1. Market Definition and Research Methodology
    1. Market Definition and Segmentation
    2. Assumptions and Acronyms
    3. Research Objective
    4. Research Methodology
  2. Executive Summary – Global Automated Cell Culture Market
  3. Market Dynamics
    1. Drivers
    2. Challenges
    3. Trends
    4. Opportunities
  4. Regulatory & Standards Landscape
  5. Industry Risk Analysis
  6. Patent Analysis
  7. Technology Analysis
  8. Average Pricing Analysis
  9. Value Chain Analysis
  10. Impact of COVID-19 on the Automated Cell Culture Market
  11. Competitive Structure
    1. Market Share Analysis, 2021
    2. Competitive Benchmarking
    3. Competitive Positioning
    4. Company Profiles
      1. Hitachi, Ltd.
      2. Thermo Fisher Scientific, Inc.
      3. Sartorius AG
      4. Hamilton Company
      5. F. Hoffmann-La Roche Ltd.
      6. Merck KGaA
      7. Becton, Dickinson, and Company
      8. Cell Culture Company, LLC
      9. Lonza Group
  12. Global Automated Cell Culture Market
    1. By Value (USD Million)
    2. Market Segmentation Analysis, 2021-2031
      1. By Product
        1. Consumables
          1. Sera, Media & Reagents
          2. Vessels
          3. Accessories
        2. Equipment
          1. Supporting Equipment
          2. Bioreactors
          3. Storage Equipment
      2. By Application
        1. Biopharmaceutical Production
        2. Tissue Engineering & Regenerative Medicine
        3. Drug Screening & Development
        4. Gene Therapy
        5. Stem Cell Research
        6. Diagnostics
        7. Toxicity Testing
        8. Others
      3. By End-User
        1. Pharmaceutical & Biotechnology Companies
        2. Hospitals & Diagnostic Laboratories
        3. Research & Academic Institutes
        4. Others
      4. By Region
        1. North America
        2. Europe
        3. Asia Pacific
        4. Latin America
        5. Middle East & Africa
  13. North America Automated Cell Culture Market
    1. By Value (USD Million)
    2. Market Segmentation Analysis, 2021-2031
      1. By Product
        1. Consumables
          1. Sera, Media & Reagents
          2. Vessels
          3. Accessories
        2. Equipment
          1. Supporting Equipment
          2. Bioreactors
          3. Storage Equipment
      2. By Application
        1. Biopharmaceutical Production
        2. Tissue Engineering & Regenerative Medicine
        3. Drug Screening & Development
        4. Gene Therapy
        5. Stem Cell Research
        6. Diagnostics
        7. Toxicity Testing
        8. Others
      3. By End-User
        1. Pharmaceutical & Biotechnology Companies
        2. Hospitals & Diagnostic Laboratories
        3. Research & Academic Institutes
        4. Others
      4. By Country
        1. United States
        2. Canada
  14. Europe Automated Cell Culture Market
    1. By Value (USD Million)
    2. Market Segmentation Analysis, 2021-2031
      1. By Product
      2. By Application
      3. By End-User
      4. By Country
        1. United Kingdom
        2. Germany
        3. Italy
        4. France
        5. Spain
        6. Russia
        7. Netherlands
        8. Rest of Europe
  15. Asia Pacific Automated Cell Culture Market
    1. By Value (USD Million)
    2. Market Segmentation Analysis, 2021-2031
      1. By Product
      2. By Application
      3. By End-User
      4. By Country
        1. Australia
        2. Japan
        3. Singapore
        4. South Korea
        5. India
        6. China
        7. Rest of Asia Pacific
  16. Latin America Automated Cell Culture Market
    1. By Value (USD Million)
    2. Market Segmentation Analysis, 2021-2031
      1. By Product
      2. By Application
      3. By End-User
      4. By Country
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  17. Middle East & Africa Automated Cell Culture Market
    1. By Value (USD Million)
    2. Market Segmentation Analysis, 2021-2031
      1. By Product
      2. By Application
      3. By End-User
      4. By Country
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa

Related Reports


Disclaimer | Privacy Policy | Terms & Conditions

Copyright © 2021 Research Nester. All Rights Reserved